ERBB2 and neoplasm: Intratumoural injection of HER2-targeted AuNPs minimized spleen and liver uptake and achieved a tumour concentration of gold (4.8 mg/g) that was expected to be sufficient to radiosensitize tumours to XRT (Cai et al. 2013).